Gulf Drug LLC

Healthcare Providers and Services, and Healthcare Technology

Targets set1.5°CNet-Zero: Committed

SBTI ID

40011269

Informations générales

Localisation

United Arab Emirates

MENA

Secteur d'activité

Healthcare Providers and Services, and Healthcare Technology

Type d'organisation

Corporate

Dernière mise à jour

08/01/2026

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Near-Term Targets: Gulf Drug LLC commits to reduce absolute scope 1 and 2 GHG emissions 42.0% by 2030 from a 2022 base year. Gulf Drug LLC also commits to reduce absolute scope 3 GHG emissions 25.0% within the same timeframe.

Net-Zero

Statut

Committed
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques